INTRODUCTION
DNA cloning is one of the most commonly used methods in molecular biology. The technique allows one to obtain a large quantity of specific DNA molecules for study or characterization. However, there is a limitation to this powerful technique. In conventional DNA cloning, a significant amount of target molecules is needed to ensure efficient ligation with vectors. With PCR, cloning trace amounts of DNA can be achieved by first amplifying the target DNA, given that partial sequences are known for the DNA segment of interest and that PCR primers can be designed. However, cloning trace amounts of DNA with unknown sequence presents a difficult task in many situations. Conventional or regular PCRbased cloning strategies are typically unable to fulfill this task.
Many amplification strategies using small amounts of DNA or RNA with unknown sequence have been reported (1) (2) (3) (4) (5) . Random primers tagged by a specific sequence at the 5′ end were commonly used to introduce primer sequences to facilitate PCR amplification (4, 5) . Most of these applications still require samples in nanogram amounts (4, 5) . To attain higher sensitivity, sequence-independent single-primer amplification (SISPA) was developed to amplify unknown target DNA molecules with PCR and has been shown to facilitate cloning from 1 pg DNA after amplification (3) . SISPA first requires ligation of an adapter onto the target population of blunt-ended DNA molecules. The resulting DNA with common end sequence allows for PCR amplification by a single primer made from the adapter sequence.
Random priming strategies generating single-stranded DNA (ssDNA) molecules are frequently used to randomly multiply DNA or synthesize cDNA from RNA molecules (6) . The most common applications include probe labeling, multiplying DNA or RNA from small samples, and generating random in vitro mutagenesis and recombination (1,2,7-10). To clone trace amounts of unknown DNA from various sources of different physical and biological properties, we have developed a two-step PCR method that is partially based on random priming strategy. The first PCR uses a single primer composed of seven random nucleotides flanked by a specific 5′ tag and a 3′ clamp (Figure 1, Ran5-29) . A PstI site (New England Biolabs, Beverly, MA, USA) is included in the 5′ tag. The internal seven random nucleotides and the 3′ clamp TGGC enable the primer to anneal with any seven nucleotides with GCCA immediately upstream. The TGGC clamp increases the primer's 3′-specific annealing from 7 to 11 nucleotides. The second PCR is performed using a single specific 
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primer (Fix5-29) matching 19 nucleotides of the 5′ tag sequence of Ran5-29. The second PCR markedly amplifies the DNA strands synthesized in the first PCR (Figure 1 ). The PstI site introduced at both ends of the PCR products facilitates cloning of the PCR products into the vector, which is linearized by the same restriction enzyme.
To demonstrate the feasibility of this cloning strategy, we used DNA preparations from human and Mycoplasma genitalium, which represents one of the most complex and one of the simplest genomes, respectively. Our results showed that with both DNA samples, this strategy could reach a cloning sensitivity of 100 fg of target DNA samples.
MATERIALS AND METHODS

DNA Preparation
Human peripheral blood DNA and M. genitalium DNA were prepared using the DNeasy ® Tissue Extraction Kit (Qiagen, Valencia, CA, USA). The DNA samples were quantitated using a MBA 2000 Spectrometer (PerkinElmer Life Sciences, Gaithersburg, MD, USA).
Random and Specific Primer PCRs
The partially random primer Ran5-29 (5′-GTTCTACACGAGTCACTG-CAGNNNNNNNTGGC-3′) was used in the first PCR. The reactions were performed in 50-µL volumes containing sample DNA, 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 2.5 mM MgCl 2 , 200 µM each dNTP, 0.5 µM primer, and 0.5 U AmpliTaq ® Gold DNA Polymerase (PerkinElmer) in a GeneAmp ® 9600 Automated Thermal Cycler (PerkinElmer). PCR conditions were 95°C for 10 min, followed by 30 cycles of 95°C for 1 min, 58°C for 1 min, 72°C for 1 min, and a final 5-min extension step at 72°C. The primer Fix5-29 (5′-GTTCTACACGAGTCACTGC-3′) was used in the second PCR. The reaction was performed under the same conditions as the first PCR, except that 55°C was used for annealing and there were 45 cycles. The products of the first PCR were purified with the GENECLEAN ® Kit (Bio101, Carlsbad, CA, USA). One quarter of each purified product was used as the template for the second PCR with the specific primer. To minimize the background DNA level, which may interfere with cloning efficiency at very low target DNA amounts, the preparation and dilution of target DNA samples were handled carefully, and reaction mixtures were prepared in a PCR workstation (Misonix, Farmingdale, NY, USA).
DNA Cloning
Target DNA samples and the vector pUC19 were digested with PstI. The linearized vector was treated with calf intestine alkaline phosphatase (CIAP; New England Biolabs) to remove the 3′ phosphate group to prevent vector selfligation. Ligation reactions were performed in 5-µL volumes containing target DNA, 0.1 µg vector, 0.5 U T4 DNA Ligase, and 1× T4 DNA Ligase Buffer (both from New England Biolabs), and incubated at 14°C overnight. The ligation mixture was used to transform Library Efficiency ® Escherichia coli DH5α Competent Cells (Invitrogen, Carlsbad, CA, USA), and the transformed E. coli cells were plated on LB agar plates containing 50 µg/mL ampicillin, 40 µg/mL isopropylthio-β-D-galactoside (IPTG), and 40 µg/mL X-gal. The plates were cultured at 37°C overnight.
Colony Screening and DNA Sequencing
E. coli colonies harboring recombinant plasmids were screened by blue and white color selection, followed by PCR with M13 forward and reverse primers. PCR was performed in 20-µL volumes containing 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 2.5 mM MgCl 2 , 200 µM each dNTP, 0.5 µM each primer, and 0.2 U AmpliTaq DNA polymerase. A white E. coli colony was inoculated into the PCR mixture as template. PCR conditions were 30 cycles of 95°C for 1 min, 55°C for 1 min, 72°C for 1 min, and a final 5-min extension step at 72°C. PCR products were gel-purified. Nucleotide sequences were determined using the flanking M13 primers using the ABI PRISM ® BigDye™ Terminator Cycle Sequencing Version 2.0 Ready Reaction Kit on 
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an ABI PRISM 377 Automated DNA Sequencer (Applied Biosystems, Foster City, CA, USA).
RESULTS AND DISCUSSION
To test the efficiency of our cloning strategy using our partially random (Ran5-29) and specific (Fix5-29) primers, human and M. genitalium DNA quantities of 1 ng, 100, 10, and 1 pg, and 100 and 10 fg were used in the Ran5-29 PCRs. Faint DNA smears were produced for each sample including double-distilled water (data not shown). Higher amounts of DNA produced slightly stronger smear signals, but dramatic differences were not observed. The smear produced by the double-distilled water as template was apparently amplified from the background DNA in our PCR systems.
The annealing temperature appeared to be important for the Ran5-29 reaction. We tested 45°, 55°, and 58°C by observing smear signals on agarose gels that were produced by the subsequent Fix5-29 PCR. At 45°C, no smear signals of the PCR products were obtained. PCR with an annealing temperature of 58°C generated more consistent smears than PCR with an annealing temperature of 55°C. As with high primer concentrations, at low temperatures, the random primer could anneal with many areas of the template with lower stringency, which favors the generation of short DNA chains (11) . At high temperatures, which is a more stringent annealing condition, primer annealing is less efficient. However, once DNA synthesis initiates, it tends to generate longer chains because the primer annealing sites are more widely spread on the template. To be amplified by primer Fix5-29, the primer sequence needs to be present at both termini of the dsDNA molecules (Figure 1) . We found that 30 cycles was optimum for Ran5-29 PCR. Ran5-29 PCR at 15 or 25 cycles significantly reduced the production of smear signals in subsequent Fix5-29 PCR and thus reduced the efficiency of obtaining recombinant plasmids in the steps that followed. On the other hand, 45 cycles of Ran5-29 PCR produced slightly more smear signals by subsequent Fix5-29 PCR but repeated cloning of identical sequences became more frequent at lower target DNA concentrations, thus reducing the overall efficiency of cloning representative DNA fragments. Forty-five cycles was found to be optimum for Fix5-29 PCR. Fewer than 40 cycles generated very weak smear signals at the femtogram target DNA level and reduced cloning efficiency. The cycle numbers for both reactions were determined for target DNA at lower than the 1 pg level. When sample DNA amounts are relatively higher, fewer cycles may be needed to amplify a sufficient amount of DNA for cloning.
The size of Fix5-29 primer PCR products ranges between 0.3 and 3 kb, with the majority in the 0.3-0.5 kb range gradually fading out after reaching 2 kb.
To facilitate the cloning of large DNA molecules, Fix5-29 PCR products between 0.5 and 2 kb were retrieved from the gel, digested with PstI, and ligated with the vector. A large number of white E. coli colonies (10 3 per transformation) were produced, while the number of blue colonies stayed at the background level, which suggests that most of the white colonies harbor recombinant plasmids as opposed to background white colonies. To select recombinant plasmids containing large inserts, we performed PCR with M13 forward and reverse primers flanking the pUC19 multiple cloning sites. We randomly examined 19 white colonies derived from each target DNA sample by PCR. Figure 2 shows the PCR products from white E. coli colonies that were derived from cloning procedures of 100, 10, and 1 pg original M. genitalium DNA samples. Similar gel electrophoresis results were obtained with other samples (data not shown). Each PCR band represents an insert amplified from the recombinant plasmid in a white E. coli colony. The average size of the inserts appeared to decrease at lower amounts of original DNA sample.
For each amount of DNA, we sequenced up to five PCR products of relatively large size with M13 forward primer. The resulting sequences were aligned with the GenBank ® Database (National Center for Biotechnol- ogy Information, National Institutes of Health, Bethesda, MD, USA) for identification. Table 1 shows the summary of the GenBank Basic Local Alignment Search Tool (BLAST ® ) results. At target DNA amounts of 100 and 10 pg of both human and M. genitalium DNA, all cloned sequences were from their respective origins. The sequences from the 1 pg human DNA sample included two groups of same human sequences, which suggests that Fix5-29 PCR products were produced from a limited variety of Ran5-29-derived templates, an expected result of low original template amounts. When we were working on 100 or 10 fg amounts of human DNA, PCR products of significant size became difficult to obtain from white E. coli colonies (Table 1) . Human sequences were still cloned from the 100-fg DNA sample, but sequences of nonhuman origins began to appear, suggesting that our PCR system has a 100-fg nonspecific background DNA level. Only two cloned sequences could be obtained from the 19 screened E. coli colonies that had originated from the 10 fg target human DNA sample; however, none were of human origin ( Table 1 ). The cloning sensitivity for M. genitalium DNA samples, in terms of target DNA amount, is similar to that of human DNA ( Table 1) .
The N7TGGC sequence introduced by PCR using the Ran5-29 primer should remain in the recombinant plasmids after the subsequent cloning procedure of the Fix5-29 PCR products. Theoretically, N7TGGC is only removed during the cloning of the PCR products that contain an internal PstI site. We found most of the cloned human sequences lacked the N7TGGC sequence, whereas most of the cloned mycoplasma sequences retained the sequence marker (Table 1) . We verified the sequences flanking the cloned PCR products that lacked the N7TGGC marker at the end(s) against the GenBank database. Over 50% of the cloned human sequences lacking the N7TGGC marker were flanked by PstI sites in the original sequence deposited in the GenBank database, while the same situation only happened in less than 20% of the cloned M. genitalium sequences lacking the N7TGGC marker. This partially explained why cloned PCR products from human DNA were generally shorter than those from M. genitalium DNA because the frequency of finding both the TGGC sequence and PstI site (CTGCAG) in human DNA should be much higher than mycoplasma DNA, which has a much smaller genome and lower GC content.
Because we know the origin of target DNA in the current study, the cloned DNA sequences can be identified directly by comparing them to the GenBank database. However, in experiments with unknown target sequences, the data obtained by alignment to GenBank provide only the information of the DNA fragments being cloned that could have been derived from the system's background. This is especially true when the DNA amount in the sample is lower than 1 pg (see Table 1 ). Further examination is necessary to correlate the cloned DNA sequences with samples of interest. In this situation, our approach for working with real samples is using PCR with primers designed from the obtained DNA sequences to examine target DNA samples. A consistent amplification of expected PCR products from samples, while not from negative PCR controls, will be evidence that the obtained sequence fragment originated from the samples.
Other researchers used random hexamers tagged with specific sequences at the 5′ end for random amplification (4, 5) . We used random heptamers and introduced a four-nucleotide TGGC clamp at the 3′ end of the random sequence. This arrangement increases the specific annealing to 11 nucleotides and therefore greatly facilitated primer binding at higher temperatures. This strategy greatly increased the amplification sensitivity achieved by tagged random hexamers. Compared with SISPA, this approach showed an over 10-fold increase in the sensitivity of cloning very small amounts of DNA. In addition, this method has the advantage of amplifying DNA in both nature and denatured forms and provides more choices of preparation methods of target DNA, which can be very difficult when working with trace amounts.
Due to its nature of random and highly sensitive amplification, this approach should be limited to dealing with trace DNA from relatively pure sources in which DNA from the background will not overcome DNA of interest. We believe this approach will be useful to characterize DNA in samples such as cultures of fastidious microorganisms, paraffin-embedded tissues, and samples from extreme harsh locations where the quantity and variety of living organisms are very low. It can also be used to amplify trace ancient DNA sequences in fossils in which the contamination of modern DNA sequences can be eliminated.
